KanoonHQ™
significantheadlines

Genericness Plea in Trademark Disputes: Two Routes to Same Answer

KanoonHQ Legal Gazette · AI-generated brief from the source linked below. How briefs are made
Published
Statutes
  • The Trademarks Act, 1999 — s.9, s.30, s.57
Bottom Line Up Front (BLUF)

The Delhi High Court, in Noviets v. Novartis, clarified that a genericness plea in trademark disputes can be raised either as a defense against infringement or as a ground for rectification/cancellation. Both routes lead to the same outcome if genericness is proven, emphasizing the importance of establishing the mark's common descriptive meaning.

Ratio Decidendi · Legal Principle Established

A trademark's genericness can be asserted defensively in an infringement suit or offensively through a rectification/cancellation petition. The legal standard for proving genericness remains consistent regardless of the procedural route chosen, focusing on whether the mark has become the common descriptive name for the goods or services.

Practice & Procedural Impact for Advocates

Advocates should consider both defensive and offensive strategies when dealing with genericness claims. Litigants must gather robust evidence demonstrating a mark's common usage to succeed on a genericness plea, irrespective of whether it's raised as a defense or for rectification.

Key Legal Takeaways

  • 1Genericness can be a defense against trademark infringement.
  • 2Genericness can be a ground for trademark rectification/cancellation.
  • 3The evidentiary standard for proving genericness is consistent across both procedural routes.

The Legal Issue

The Delhi High Court addressed the procedural avenues available for raising a plea of genericness in trademark disputes. Specifically, the court considered whether genericness could only be a ground for rectification or cancellation of a trademark under Section 57 of The Trademarks Act, 1999, or if it could also be raised as a defense against a claim of trademark infringement under Section 30 of the same Act. The core question revolved around the flexibility and equivalence of these two procedural routes in achieving the same substantive outcome: invalidating a mark due to its generic nature.

Court's Reasoning

The Delhi High Court clarified that a plea of genericness can indeed be raised through two distinct, yet equally effective, routes. Firstly, it can be asserted as a defense to an infringement action, arguing that the plaintiff's mark is generic and therefore not entitled to protection. Secondly, it can be a direct ground for seeking rectification or cancellation of the trademark registration itself. The Court emphasized that the substantive test for genericness—whether the mark has become the common descriptive name for the goods or services—remains the same, irrespective of the procedural path chosen. The Court referenced Section 9, which deals with absolute grounds for refusal of registration, including generic marks, and Section 30, which outlines limitations on the effect of a registered trademark, implicitly allowing for defenses like genericness. The Court's reasoning underscores that the law aims for a just outcome based on the mark's actual nature, rather than being constrained by procedural technicalities.

Why It Matters

This ruling is significant for trademark litigation in India as it provides clarity and flexibility for parties challenging the validity of a registered trademark on grounds of genericness. It confirms that a defendant in an infringement suit is not necessarily compelled to initiate a separate rectification proceeding to raise genericness. This can streamline litigation, reduce costs, and prevent multiplicity of proceedings. For trademark owners, it highlights the importance of actively monitoring the market to prevent their marks from becoming generic, as such a development could render their registrations vulnerable to challenge through multiple avenues. For advocates, it means a broader strategic toolkit when advising clients on both enforcing and defending trademark rights, ensuring that the most efficient and effective route is chosen to address genericness claims.

Read the Bar & Bench report